These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 12807432)

  • 41. The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation.
    Mühlenbeck F; Schneider P; Bodmer JL; Schwenzer R; Hauser A; Schubert G; Scheurich P; Moosmayer D; Tschopp J; Wajant H
    J Biol Chem; 2000 Oct; 275(41):32208-13. PubMed ID: 10807904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. eNOS protects prostate cancer cells from TRAIL-induced apoptosis.
    Tong X; Li H
    Cancer Lett; 2004 Jul; 210(1):63-71. PubMed ID: 15172122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.
    Eggert A; Grotzer MA; Zuzak TJ; Wiewrodt BR; Ho R; Ikegaki N; Brodeur GM
    Cancer Res; 2001 Feb; 61(4):1314-9. PubMed ID: 11245427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
    Chen X; Thakkar H; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
    Oncogene; 2001 Sep; 20(42):6073-83. PubMed ID: 11593415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R; Bedi A
    Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinase.
    Sah NK; Munshi A; Kurland JF; McDonnell TJ; Su B; Meyn RE
    J Biol Chem; 2003 Jun; 278(23):20593-602. PubMed ID: 12663665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway.
    Nam SY; Amoscato AA; Lee YJ
    Oncogene; 2002 Jan; 21(3):337-46. PubMed ID: 11821946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fucoxanthin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Synergistically Promotes Apoptosis of Human Cervical Cancer Cells by Targeting PI3K/Akt/NF-κB Signaling Pathway.
    Jin Y; Qiu S; Shao N; Zheng J
    Med Sci Monit; 2018 Jan; 24():11-18. PubMed ID: 29291370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.
    Nakshatri H; Rice SE; Bhat-Nakshatri P
    Oncogene; 2004 Sep; 23(44):7330-44. PubMed ID: 15286701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.
    Oya M; Ohtsubo M; Takayanagi A; Tachibana M; Shimizu N; Murai M
    Oncogene; 2001 Jun; 20(29):3888-96. PubMed ID: 11439352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB.
    Ravi R; Bedi GC; Engstrom LW; Zeng Q; Mookerjee B; Gélinas C; Fuchs EJ; Bedi A
    Nat Cell Biol; 2001 Apr; 3(4):409-16. PubMed ID: 11283615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL.
    Chawla-Sarkar M; Bauer JA; Lupica JA; Morrison BH; Tang Z; Oates RK; Almasan A; DiDonato JA; Borden EC; Lindner DJ
    J Biol Chem; 2003 Oct; 278(41):39461-9. PubMed ID: 12881518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein kinase C-epsilon regulates the apoptosis and survival of glioma cells.
    Okhrimenko H; Lu W; Xiang C; Hamburger N; Kazimirsky G; Brodie C
    Cancer Res; 2005 Aug; 65(16):7301-9. PubMed ID: 16103081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Etoposide upregulates Bax-enhancing tumour necrosis factor-related apoptosis inducing ligand-mediated apoptosis in the human hepatocellular carcinoma cell line QGY-7703.
    Miao L; Yi P; Wang Y; Wu M
    Eur J Biochem; 2003 Jul; 270(13):2721-31. PubMed ID: 12823542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
    Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
    Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones.
    Crossthwaite AJ; Valli H; Williams RJ
    J Neurochem; 2004 Mar; 88(5):1127-39. PubMed ID: 15009668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells.
    Oka N; Nakahara S; Takenaka Y; Fukumori T; Hogan V; Kanayama HO; Yanagawa T; Raz A
    Cancer Res; 2005 Sep; 65(17):7546-53. PubMed ID: 16140916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathways involved in proliferating, senescent and immortalized keratinocyte cell death mediated by two different TRAIL preparations.
    Qin JZ; Bacon PE; Chaturvedi V; Bonish B; Nickoloff BJ
    Exp Dermatol; 2002 Dec; 11(6):573-83. PubMed ID: 12473065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.